CTCF and central nervous system cancer: This hypothesis has been recently corroborated by the finding that DNA hypermethylation causes reduced CCCTC-binding factor (CTCF) binding to DNA, leading to aberrant activation of the oncogene Platelet-derived growth factor receptor (PDGFRA) [81] in gliomas.